Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal The New York TimesPfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits CNBCPfizer Clinches Deal for Obesity Drug Developer Metsea After a Bidding War With Novo Nordisk U.S. News & World ReportNovo's CEO Turns to Next Targets After Losing Metsera to Pfizer Bloomberg.com
